ADAM17 and neoplasm: In renal carcinoma context, studies have reported (i) an increased expression of ADAM10 and ADAM17 in renal cancer tissues and cell lines [36, 37] and (ii) that renal cancer cells failed to develop tumours in vivo in the absence of ADAM17 [38].